Sanofi Thailand Wins Fifth Consecutive AmCham Impact Award

Sanofi, a leading global healthcare company, has received the “Corporate Social Impact Award 2024 – Gold level” for the fifth consecutive year from the American Chamber of Commerce in Thailand (AmCham Thailand), reaffirming its commitment to business practices rooted in social and community responsibility. The company continues to support initiatives that enhance the well-being of Thai society and promote sustainability. Representing Sanofi Thailand, Ms Mantana Tanprasert, Head of Vaccines for Thailand and Myanmar, and Mr Charles Trolliet, Head of Commercial Thailand, Pharma Business, proudly accepted the award at Avani+ Riverside Bangkok Hotel recently.
Since its inception, Sanofi Thailand has consistently implemented innovative approaches to prevent and treat medical conditions, benefiting both patients and the general public. The company’s cutting-edge science and manufacturing, powered by data and digital technologies, drive the transformation of scientific advances into healthcare solutions. Sanofi’s contributions span from preventing illnesses through vaccines to providing treatments that alleviate pain and improve quality of life. This includes dedicated support for patients with rare diseases and the millions managing chronic conditions.
Mr Eric Mansion, General Manager, Pharma Business of South-East Asia & India (SEA&I) and Multi-Country Organization (MCO) Lead, shared, “At Sanofi, a global leader in healthcare innovation with operations in over 70 countries, we are united by our purpose: ‘We Chase the Miracles of Science to Improve People’s Lives.’ Our commitment to research and development propels us to deliver best-in-class solutions, using advanced technology and a patient-centric approach. In the rapidly growing SEA&I region, with over 2 billion people, we understand that healthcare access, environmental care, and social impact are all essential. Sanofi prioritises disease awareness campaigns to empower self-care and promotes environmental consciousness as part of our holistic mission to improve lives.”
Mr Charles Trolliet, who supports and drives social impact projects in Thailand, remarked, “Sanofi Thailand strives to provide Thai patients with equitable, sustainable access to innovative treatments and has launched two pioneering projects this year:
Ms Mantana Tanprasert, Head of Vaccines for Thailand and Myanmar, added, “This award inspires us to deepen our commitment to scientific innovation that enhances the health of Thai society. Our efforts have yielded tangible results, from providing life-changing treatment options and promoting health literacy to advocating for life-course immunisation, especially for vulnerable groups like infants, children, and the elderly. We reaffirm our commitment to improving the health and well-being of communities in Thailand.”
Receiving the AmCham Corporate Social Impact Award 2024 is an honour that aligns with Sanofi’s purpose: “We Chase the Miracles of Science to Improve People’s Lives.” Sanofi’s dedication to advancing healthcare extends beyond innovations, fostering health equity, and caring for the planet to create a lasting, positive impact in the communities it serves.